loadpatents
Patent applications and USPTO patent grants for KELSOE; Garnett.The latest application filed is for "monoclonal antibodies for prevention and treatment of herpes simplex viral infections".
Patent | Date |
---|---|
Monoclonal Antibodies For Prevention And Treatment Of Herpes Simplex Viral Infections App 20220162291 - HEROLD; Betsy C. ;   et al. | 2022-05-26 |
Methods to identify prime and boost immunogens for use in a B cell lineage-based vaccination protocol Grant 10,835,599 - Haynes , et al. November 17, 2 | 2020-11-17 |
B cell lineage based immunogen design with humanized animals Grant 10,626,168 - Haynes , et al. | 2020-04-21 |
Vaccine App 20190167783 - HAYNES; Barton F. ;   et al. | 2019-06-06 |
B Cell Lineage Based Immunogen Design With Humanized Animals App 20180298082 - Haynes; Barton ;   et al. | 2018-10-18 |
GP120 immunogens and methods inducing neutralizing antibodies to human immunodeficiency virus Grant 10,092,638 - Haynes , et al. October 9, 2 | 2018-10-09 |
B cell lineage based immunogen design with humanized animals Grant 9,963,501 - Haynes , et al. May 8, 2 | 2018-05-08 |
Compositions And Methods For Transient Immune Response Modulation During Vaccination App 20170216426 - HAYNES; Barton F. ;   et al. | 2017-08-03 |
Method Of Inducing The Production Of Protective Anti-hiv-1 Antibodies App 20160271244 - Haynes; Barton F. ;   et al. | 2016-09-22 |
Adjuvant Grant 8,926,995 - Haynes , et al. January 6, 2 | 2015-01-06 |
Vaccine App 20140341949 - Haynes; Barton F. ;   et al. | 2014-11-20 |
B Cell Lineage Based Immunogen Design With Humanized Animals App 20140221625 - HAYNES; BARTON ;   et al. | 2014-08-07 |
Adjuvant App 20130243850 - Haynes; Barton F. ;   et al. | 2013-09-19 |
Method Of Inducing The Production Of Protective Anti-hiv-1 Antibodies App 20120321699 - Haynes; Barton F. ;   et al. | 2012-12-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.